Gara Jalqabaatti › Dukkana Bladder › North Carolina › Durham
Qorannoo klinikaalii Dukkana Bladder Durham, NC keessatti
Qorannoo 20 Dukkana Bladder f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Vanguard Study: Testing a New Way to Screen for Cancer
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Namoota walitti qabaa jiraSadarkaa 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Durham VA Medical Center, Durham
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Namoota walitti qabaa jiraSadarkaa 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- Duke University Medical Center, Durham
- fi 1 dabalataa
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Biorepository and Precision Pathology Center (BRPC), Durham
- Duke Cancer Institute, Durham
- Substrate Services Core Research Support (SSCRS), Durham
DESTINY-PANTUMOUR04
Namoota walitti qabaa jiraQorannoo ilaalaa
- Research Site, Durham
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Medical Center - Duke Cancer Center, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Namoota walitti qabaa jiraQorannoo ilaalaa
- UNC- Chapel Hill, Chapel Hill · Miili 10 fagaatti
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Namoota walitti qabaa jiraSadarkaa 2
- University of North Carolina, Chapel Hill · Miili 10 fagaatti
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Namoota walitti qabaa jiraSadarkaa 2/3
- Research Site, Chapel Hill · Miili 10 fagaatti
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Namoota walitti qabaa jiraSadarkaa 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · Miili 10 fagaatti
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke Health - Duke Cancer Center, Durham
- UNC Chapel Hill Hospital, Chapel Hill · Miili 10 fagaatti
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of North Carolina, Chapel Hill · Miili 10 fagaatti
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Namoota walitti qabaa jiraSadarkaa 2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill · Miili 10 fagaatti
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Namoota walitti qabaa jira
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · Miili 10 fagaatti
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Chapel Hill · Miili 10 fagaatti
Qorannoo Dukkana Bladder magaalota biroo keessatti
- New York City, NYQorannoo 35
- Nashville, TNQorannoo 31
- Houston, TXQorannoo 31
- Dallas, TXQorannoo 27
- Washington, DCQorannoo 26
- Boston, MAQorannoo 26
- Baltimore, MDQorannoo 24
- Los Angeles, CAQorannoo 24
- St. Louis, MOQorannoo 22
- Seattle, WAQorannoo 21
- Chicago, ILQorannoo 21
- Philadelphia, PAQorannoo 21
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 64
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Leukemia Myeloidii HamaaQorannoo 33
- Kansara MetastatikiiQorannoo 33
- Kansarii ProstateQorannoo 32
- Dhibee QaraQorannoo 32
- Kansarii ColorectalQorannoo 28
- Kansarii OvariiQorannoo 27
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.